Secukinumab-Induced Lymphocytic Colitis

Secukinumab an interleukin-17 (IL-17) monoclonal antibody inhibitor is currently approved for the treatment of rheumatological conditions, such as psoriasis and ankylosing spondylitis. Lymphocytic colitis, a phenotype of microscopic colitis, is a long-term inflammatory condition, is characterized by...

Full description

Saved in:
Bibliographic Details
Main Authors: Siva Santosh Kumar Gandu MD (Author), Mohammad Hassaan Khan MD (Author), Anush Vasikaran MD (Author), Sudha Pandit MD (Author)
Format: Book
Published: SAGE Publishing, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available